LDL-C Reduction after Acute Coronary Syndrome: How to reconcile practice with current guidelines?
Patients admitted for an Acute Coronary Syndrome must be treated with high intensity statins, as early as possible and irrespective of the LDL-C level. LDL-C level at admission is helpful to guide treatment intensity, in order to reach the target LDL-C below 70mg/dL, ideally, 55mg/dL. The addition of ezetimibe, on top of statins, might be necessary to reach the LDL-C target, according to the LDL-C at admission. Scientific rationale and modalities of lipid lowering treatment before discharge are discussed.